Variant report
Variant | nsv969923 |
---|---|
Chromosome Location | chr5:42919063-42930741 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:42924589..42926644-chr5:42983759..42986055,2 | MCF-7 | breast: | |
2 | chr5:42911638..42913879-chr5:42921699..42924243,2 | K562 | blood: | |
3 | chr5:42923915..42925843-chr5:42928024..42929691,2 | K562 | blood: | |
4 | chr5:42914797..42917737-chr5:42919672..42921552,2 | K562 | blood: | |
5 | chr5:42927540..42930001-chr5:43065778..43067450,2 | MCF-7 | breast: | |
6 | chr5:42919032..42920637-chr5:42923074..42925674,2 | K562 | blood: | |
7 | chr5:42928813..42931600-chr5:43007922..43010335,2 | MCF-7 | breast: | |
8 | chr5:42919032..42920637-chr5:42923074..42925674,2 | K562 | blood: | |
9 | chr5:42923915..42925843-chr5:42928024..42929691,2 | K562 | blood: |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SEPP1-1 | chr5:42919976-42920126 | XLOC_004802 |
2 | lnc-SEPP1-1 | chr5:42919975-42920126 | NONHSAT101235 |
3 | lnc-CCDC152-1 | chr5:42922836-42922975 | XLOC_004361 |
4 | lnc-CCDC152-1 | chr5:42923787-42924839 | XLOC_004361 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249516 | chromatin interactions |
KIAA0494 | miRNA target sites |
NFIX | miRNA target sites |
TBC1D14 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2548366 | chr5:42919122-42919123 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs531473101 | chr5:42919168-42919169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs150050366 | chr5:42919232-42919233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567949761 | chr5:42919233-42919234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529046337 | chr5:42919268-42919269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2548367 | chr5:42919269-42919270 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs6451655 | chr5:42919280-42919281 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs186850399 | chr5:42919340-42919341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562701506 | chr5:42919354-42919355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs145406973 | chr5:42919355-42919356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553906287 | chr5:42919369-42919370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11289952 | chr5:42919391-42919392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531915445 | chr5:42919394-42919395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113802442 | chr5:42919403-42919404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs556885521 | chr5:42919406-42919407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575129604 | chr5:42919408-42919409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372932517 | chr5:42919409-42919410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553982892 | chr5:42919421-42919422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548836228 | chr5:42919424-42919425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs76916775 | chr5:42919437-42919438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs376717069 | chr5:42919450-42919451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184986500 | chr5:42919462-42919463 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564531777 | chr5:42919474-42919475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189968095 | chr5:42919479-42919480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs62372097 | chr5:42919482-42919483 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs62372098 | chr5:42919521-42919522 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs145227721 | chr5:42919548-42919549 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544224204 | chr5:42919563-42919564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547531066 | chr5:42919594-42919595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs182136041 | chr5:42919609-42919610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs59714873 | chr5:42919644-42919645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551169324 | chr5:42919681-42919682 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs6451656 | chr5:42919685-42919686 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs529763746 | chr5:42919687-42919688 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs537039094 | chr5:42919734-42919735 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs557851600 | chr5:42919778-42919779 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs149711614 | chr5:42919799-42919800 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs377749256 | chr5:42919839-42919840 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs185192624 | chr5:42919840-42919841 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs373536412 | chr5:42919843-42919844 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs140876599 | chr5:42919845-42919846 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs568727994 | chr5:42919877-42919878 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs536070378 | chr5:42919890-42919891 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs189224616 | chr5:42919900-42919901 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs554315222 | chr5:42919927-42919928 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs2548368 | chr5:42919979-42919980 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs117982437 | chr5:42920006-42920007 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs527520109 | chr5:42920040-42920041 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs181942462 | chr5:42920089-42920090 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs543366485 | chr5:42920094-42920095 | Weak transcription | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Breast cancer | 21364760 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:42916000-42929400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr5:42923600-42923800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr5:42924000-42924400 | Bivalent/Poised TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr5:42924000-42924600 | Active TSS | Primary neutrophils fromperipheralblood | blood |
5 | chr5:42924000-42924600 | Flanking Bivalent TSS/Enh | Foreskin Fibroblast Primary Cells skin01 | Skin |
6 | chr5:42924000-42924800 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr5:42924200-42924400 | Bivalent/Poised TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
8 | chr5:42924200-42924400 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
9 | chr5:42924400-42924600 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr5:42924600-42924800 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr5:42924600-42924800 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
12 | chr5:42924600-42925800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
13 | chr5:42925800-42926400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
14 | chr5:42928800-42929200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr5:42929800-42930200 | Enhancers | HUVEC | blood vessel |
16 | chr5:42930000-42931200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr5:42930000-42931200 | Enhancers | NHEK | skin |
18 | chr5:42930000-42931600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
19 | chr5:42930600-42931000 | Enhancers | HMEC | breast |